Research ExplorerScientific StaffNicolaus-Martin Kröger Publications

Prof. Dr. ID: 37856

Nicolaus-Martin Kröger

Head of Clinic

graph of relations
Affiliations
651 - 700 out of 776Page size: 50

Publications

  1. 2010

  2. Comparison of cytogenetic clonal evolution patterns following allogeneic hematopoietic transplantation versus conventional treatment in patients at relapse of AML.

    Bacher, U., Haferlach, T., Alpermann, T., Zenger, M., Kröger, N., Beelen, D. W., Kern, W., Schnittger, S. & Haferlach, C., 2010, In: BIOL BLOOD MARROW TR. 16, 12, p. 1649-1657 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny.

    Cavattoni, I., Ayuketang Ayuk, F., Zander, A. R., Zabelina, T., Bacher, A., Cayiroglu, E., Knospe, V., Illies, T., Aepfelbacher, M., Richard, G., Kröger, N. & Bacher, U., 2010, In: LEUKEMIA LYMPHOMA. 51, 8, p. 1530-1535 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Diagnostic tools in the indications for allogeneic stem cell transplantation in myelodysplastic syndromes.

    Bacher, U., Haferlach, C., Kröger, N., Schnittger, S., Kern, W., Wiedemann, B., Zander, A. R. & Haferlach, T., 2010, In: BIOL BLOOD MARROW TR. 16, 1, p. 1-11 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.

    Pabst, C., Zustin, J., Jacobsen, F., Luetkens, T., Kröger, N., Schilling, G., Bokemeyer, C., Sauter, G., Atanackovic, D. & Marx, A., 2010, In: EXP MOL PATHOL. 89, 2, p. 175-181 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.

    Luetkens, T., Schafhausen, P., Uhlich, F., Stasche, T., Akbulak, R. Ö., Bartels, B. M., Hildebrandt, Y., Gontarewicz, A., Kobold, S., Meyer, S., Gordic, M., Bartels, K., Lajmi, N., Cao, Y., Kröger, N., Bokemeyer, C., Brümmendorf, T. & Atanackovic, D., 2010, In: LEUKEMIA RES. 34, 12, p. 1647-1655 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis.

    Alchalby, H., Badbaran, A., Zabelina, T., Kobbe, G., Hahn, J., Wolff, D., Bornhäuser, M., Christian, T., Baurmann, H., Bethge, W., Hildebrandt, Y., Bacher, U., Fehse, B., Zander, A. R. & Kröger, N., 2010, In: BLOOD. 116, 18, p. 3572-3581 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Influence on Busilvex pharmacokinetics of clonazepam compared to previous phenytoin historical data.

    Carreras, E., Cahn, J. Y., Puozzo, C., Kröger, N., Sanz, G., Buzyn, A., Bacigalupo, A. & Vernant, J. P., 2010, In: ANTICANCER RES. 30, 7, p. 2977-2984 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma.

    Lokhorst, H., Einsele, H., Vesole, D., Bruno, B., Jesus, S. M., Pérez-Simon, J. A., Kröger, N., Moreau, P., Gahrton, G., Gasparetto, C., Giralt, S. & Bensinger, W., 2010, In: J CLIN ONCOL. 28, 29, p. 4521-4530 29.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

    Bishop, M. R., Alyea, E. P., Cairo, M. S., Falkenburg, J. H. F., June, C. H., Kröger, N., Little, R. F., Miller, J. S., Pavletic, S. Z., Porter, D., Riddell, S. R., van Besien, K., Wayne, A. S., Weisdorf, D. J., Wu, R. & Giralt, S., 2010, In: BIOL BLOOD MARROW TR. 16, 5, p. 563-564 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Long-term follow-up of an intensified myeloablative conditioning regimen with in vivo T cell depletion followed by allografting in patients with advanced multiple myeloma.

    Kröger, N., Einsele, H., Derigs, G., Wandt, H., Krüll, A. & Zander, A. R., 2010, In: BIOL BLOOD MARROW TR. 16, 6, p. 861-864 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

    Kyle, R. A., Durie, B. G. M., Rajkumar, S. V., Landgren, O., Blade, J., Merlini, G., Kröger, N., Einsele, H., Vesole, D. H., Dimopoulos, M., San Miguel, J., Avet-Loiseau, H., Hajek, R., Chen, W. M., Anderson, K. C., Ludwig, H., Sonneveld, P., Pavlovsky, S., Palumbo, A., Richardson, P. G., Barlogie, B., Greipp, P., Vescio, R., Turesson, I., Westin, J., Boccadoro, M. & Group, I. M. W., 2010, In: LEUKEMIA. 24, 6, p. 1121-1127 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies.

    Kröger, N., Bacher, U., Bader, P., Böttcher, S., Borowitz, M. J., Dreger, P., Khouri, I., Olavarria, E., Radich, J., Stock, W., Vose, J. M., Weisdorf, D., Willasch, A., Giralt, S., Bishop, M. R. & Wayne, A. S., 2010, In: BIOL BLOOD MARROW TR. 16, 10, p. 1325-1346 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes.

    Kröger, N., Bacher, U., Bader, P., Böttcher, S., Borowitz, M. J., Dreger, P., Khouri, I., Macapinlac, H. A., Macapintac, H., Olavarria, E., Radich, J., Stock, W., Vose, J. M., Weisdorf, D., Willasch, A., Giralt, S., Bishop, M. R. & Wayne, A. S., 2010, In: BIOL BLOOD MARROW TR. 16, 9, p. 1187-1211 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Peptide length extension skews the minor HA-1 antigen presentation toward activated dendritic cells but reduces its presentation efficiency.

    Hambach, L., Aghai, Z., Pool, J., Kröger, N. & Goulmy, E., 2010, In: J IMMUNOL. 185, 8, p. 4582-4589 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation.

    Cavattoni, I., Zabelina, T., Ayuketang Ayuk, F., Wolschke, C., Bacher, U., Zander, A. R. & Kröger, N., 2010, In: LEUKEMIA LYMPHOMA. 51, 1, p. 146-148 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Post-transplant immune reconstitution after unrelated allogeneic stem cell transplant in patients with acute myeloid leukemia.

    Klyuchnikov, E., Asenova, S., Kern, W., Kilinc, G., Ayuketang Ayuk, F., Wiedemann, B., Lioznov, M., Freiberger, P., Zalyalov, Y., Zander, A. R., Kröger, N. & Bacher, U., 2010, In: LEUKEMIA LYMPHOMA. 51, 8, p. 1450-1463 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Questionable role of free light chain assay ratio to determine stringent complete remission in multiple myeloma patients.

    Kröger, N., Asenova, S., Gerritzen, A., Bacher, U. & Zander, A. R., 2010, In: BLOOD. 115, 16, p. 3413-3415 16.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in myelofibrosis.

    Alchalby, H. & Kröger, N., 2010, In: CURR HEMATOL MALIG R. 5, 2, p. 53-61 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.

    Alchalby, H., Badbaran, A., Bock, O., Fehse, B., Bacher, U., Zander, A. R. & Kröger, N., 2010, In: BONE MARROW TRANSPL. 45, 9, p. 1404-1407 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Second Allogeneic Stem Cell Transplantation in a Patient with Hypoplastic Myelodysplastic Syndrome following a Primary Diagnosis of Aplastic Anaemia.

    Ocheni, S., Oyekunle, A., Kröger, N., Ayuketang Ayuk, F., Klyuchnikov, E., Arps, S., Held, K., Zabelina, T., Adjalle, R., Wolschke, C., Zander, A. R. & Bacher, U., 2010, In: ACTA HAEMATOL-BASEL. 125, 3, p. 175-178 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT.

    Koenecke, C., Hertenstein, B., Schetelig, J., van Biezen, A., Dammann, E., Gratwohl, A., Ganser, A., Schleuning, M., Bornhäuser, M., Jacobsen, N., Kröger, N., Niederwieser, D., de Witte, T. & Ruutu, T., 2010, In: AM J TRANSPLANT. 10, 8, p. 1897-1906 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.

    Cao, Y., Luetkens, T., Kobold, S., Hildebrandt, Y., Gordic, M., Lajmi, N., Meyer, S., Bartels, K., Zander, A. R., Bokemeyer, C., Kröger, N. & Atanackovic, D., 2010, In: EXP HEMATOL. 38, 10, p. 860-867 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.

    Kröger, N., Shimoni, A., Schilling, G., Schwerdtfeger, R., Bornhäuser, M., Nagler, A., Zander, A. R., Heinzelmann, M., Brand, R., Gahrton, G., Morris, C., Niederwieser, D. & de Witte, T., 2010, In: BRIT J HAEMATOL. 148, 2, p. 323-331 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Unrelated stem cell transplantation for patients with multiple myeloma.

    Kröger, N., 2010, In: CURR OPIN HEMATOL. 17, 6, p. 538-543 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. 2009

  27. 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis.

    Czibere, A., Bruns, I., Kröger, N., Platzbecker, U., Lind, J., Zohren, F., Fenk, R., Germing, U., Schröder, T., Gräf, T., Haas, R. & Kobbe, G., 2009, In: BONE MARROW TRANSPL. *45*, 5, p. 872-876 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

    Kröger, N., Holler, E., Kobbe, G., Bornhäuser, M., Schwerdtfeger, R., Baurmann, H., Nagler, A., Bethge, W., Stelljes, M., Uharek, L., Wandt, H., Burchert, A., Corradini, P., Schubert, J., Kaufmann, M., Dreger, P., Wulf, G. G., Einsele, H., Zabelina, T., Kvasnicka, H. M., Thiele, J., Brand, R., Zander, A. R., Niederwieser, D., Witte, D. & Theo, M., 2009, In: BLOOD. 114, 26, p. 5264-5270 26.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival.

    de Witte, T., Brand, R., van Biezen, A., Mufti, G., Ruutu, T., Finke, J., von Dem Borne, P., Vitek, A., Delforge, M., Alessandrino, P., Harlahakis, N., Russell, N., Martino, R., Verdonck, L., Kröger, N. & Niederwieser, D., 2009, In: BRIT J HAEMATOL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Antitumor effects of polyclonal antithymocyte globulins: focus on B-cell malignancies and multiple myeloma.

    Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 2009, In: ANN HEMATOL. 88, 5, p. 401-404 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis.

    Gupta, V., Kröger, N., Aschan, J., Xu, W., Leber, B., Dalley, C., Sabloff, M., Lipton, J. H., Messner, H. & Brune, M., 2009, In: BONE MARROW TRANSPL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Biclonal expansion and heterogeneous lineage involvement in a case of chronic myeloproliferative disease with concurrent MPLW515L/JAK2V617F mutation.

    Hussein, K., Bock, O., Theophile, K., Schlue, J., Ballmaier, M., Kröger, N., Göhring, G., Büsche, G. & Kreipe, H., 2009, In: BLOOD. 113, 6, p. 1391-1392 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.

    Bacher, U., Asenova, S., Badbaran, A., Zander, A. R., Alchalby, H., Fehse, B., Kröger, N., Lange, C. & Ayuketang Ayuk, F., 2009, In: CLIN EXP MED.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.

    Atanackovic, D., Hildebrandt, Y., Jadczak, A., Cao, Y., Luetkens, T., Meyer, S., Kobold, S., Bartels, K., Pabst, C., Lajmi, N., Gordic, M., Stahl, T., Zander, A. R., Bokemeyer, C. & Kröger, N., 2009, In: HAEMATOLOGICA. *95*, 5, p. 785-793 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.

    Ocheni, S., Iwanski, G., Schafhausen, P., Zander, A. R., Ayuketang Ayuk, F., Klyuchnikov, E., Zabelina, T., Fiedler, W., Schnittger, S., Hochhaus, A., Brümmendorf, T., Kröger, N. & Bacher, U., 2009, In: LEUKEMIA LYMPHOMA. 50, 4, p. 551-558 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Comparison of the cytotoxicity of 4 preparations of anti-T-cell globulins in various hematological malignancies.

    Ayuketang Ayuk, F., Maywald, N., Hannemann, S., Larsen, U., Zander, A. R. & Kröger, N., 2009, In: ANTICANCER RES. 29, 4, p. 1355-1360 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Concordance of assays designed for the quantification of JAK2V617F: a multicenter study.

    Lippert, E., Girodon, F., Hammond, E., Jelinek, J., Reading, N. S., Fehse, B., Hanlon, K., Hermans, M., Richard, C., Swierczek, S., Ugo, V., Carillo, S., Harrivel, V., Marzac, C., Pietra, D., Sobas, M., Mounier, M., Migeon, M., Ellard, S., Kröger, N., Herrmann, R., Prchal, J. T., Skoda, R. C. & Hermouet, S., 2009, In: HAEMATOLOGICA. 94, 1, p. 38-45 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Current status and perspectives of tyrosine kinase inhibitor treatment in the post-transplant period in patients with chronic myeloid leukemia (CML).

    Klyuchnikov, E., Kröger, N., Brümmendorf, T., Wiedemann, B., Zander, A. R. & Bacher, U., 2009, In: BIOL BLOOD MARROW TR.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Donor lymphocyte infusions in amyloid light chain amyloidosis: induction of a "graft-versus-plasma cell-dyscrasia effect".

    Schonland, S. O., Kröger, N., Wolschke, C., Dreger, P., Ho, A. D. & Hegenbart, U., 2009, In: HAEMATOLOGICA. 94, 3, p. 439-441 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

    Kröger, N., Zabelina, T., Binder, T., Ayuketang Ayuk, F., Bacher, U., Amtsfeld, G., Lellek, H., Schrum, J., Erttmann, R., Eiermann, T. & Zander, A. R., 2009, In: BIOL BLOOD MARROW TR. 15, 4, p. 454-462 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Identification of new target molecules PTK2, TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosis.

    Bock, O., Muth, M., Theophile, K., Winter, M., Hussein, K., Büsche, G., Kröger, N. & Kreipe, H., 2009, In: BRIT J HAEMATOL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Interactive diagnostics in the indication to allogeneic SCT in AML.

    Bacher, U., Haferlach, C., Schnittger, S., Kern, W., Kröger, N., Zander, A. R. & Haferlach, T., 2009, In: BONE MARROW TRANSPL. 43, 10, p. 745-756 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

    Kröger, N., Alchalby, H., Klyuchnikov, E., Badbaran, A., Hildebrandt, Y., Ayuketang Ayuk, F., Bacher, U., Bock, O., Kvasnicka, M., Fehse, B. & Zander, A. R., 2009, In: BLOOD. 113, 8, p. 1866-1868 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

    Lioznov, M., El-Cheikh, J., Hoffmann, F., Hildebrandt, Y., Ayuketang Ayuk, F., Wolschke, C., Atanackovic, D., Schilling, G., Badbaran, A., Bacher, U., Fehse, B., Zander, A. R., Blaise, D., Mohty, M. & Kröger, N., 2009, In: BONE MARROW TRANSPL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.

    Atanackovic, D., Luetkens, T., Hildebrandt, Y., Arfsten, J., Bartels, K., Horn, C., Stahl, T., Cao, Y., Zander, A. R., Bokemeyer, C. & Kröger, N., 2009, In: CLIN CANCER RES. 15, 4, p. 1343-1352 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Outcome of allo-SCT for chronic myelomonocytic leukemia.

    Ocheni, S., Kröger, N., Zabelina, T., Zander, A. R. & Bacher, U., 2009, In: BONE MARROW TRANSPL. 43, 8, p. 659-661 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Outcome of transplantation for myelofibrosis.

    Ballen, K. K., Shrestha, S., Sobocinski, K. A., Zhang, M-J., Bashey, A., Bolwell, B. J., Cervantes, F., Devine, S. M., Gale, R. P., Gupta, V., Hahn, T. E., Hogan, W. J., Kröger, N., Litzow, M. R., Marks, D. I., Maziarz, R. T., McCarthy, P. L., Schiller, G., Harry, C. S., Roy, V., Wiernik, P. H., Horowitz, M. M., Giralt, S. A. & Arora, M., 2009, In: BIOL BLOOD MARROW TR. *16*, 3, p. 358-367 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.

    Ocheni, S., Zabelina, T., Bacher, U., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 2009, In: LEUKEMIA LYMPHOMA. 50, 4, p. 612-618 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

    Kröger, N., Badbaran, A., Lioznov, M., Schwartz, S., Zeschke, S., Hildebrandt, Y., Ayuketang Ayuk, F., Atanackovic, D., Schilling, G., Zabelina, T., Bacher, U., Klyuchnikov, E., Shimoni, A., Nagler, A., Corradini, P., Fehse, B. & Zander, A. R., 2009, In: EXP HEMATOL. 37, 7, p. 791-798 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.

    Bacher, U., Badbaran, A., Fehse, B., Zabelina, T., Zander, A. R. & Kröger, N., 2009, In: EXP HEMATOL. 37, 1, p. 135-142 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.

    Kröger, N., Brand, R., van Biezen, A., Zander, A. R., Dierlamm, J., Niederwieser, D., Devergie, A., Ruutu, T., Cornish, J., Ljungman, P., Gratwohl, A., Cordonnier, C., Beelen, D., Deconinck, E., Symeonidis, A. & de Witte, T., 2009, In: HAEMATOLOGICA. 94, 4, p. 542-549 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Safety of conditioning agents for allogeneic haematopoietic transplantation.

    Bacher, U., Klyuchnikov, E., Wiedemann, B., Kröger, N. & Zander, A. R., 2009, In: EXPERT OPIN DRUG SAF. 8, 3, p. 305-315 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...10 11 12 13 14 15 16 Next